Pharmaceutical Companies

Who is Challenging the Medicare Drug Price Negotiation Rule?

October 12, 2023 - The Medicare drug price negotiation provisions in the Inflation Reduction Act hold promising spending reductions for beneficiaries, but drug companies are not backing down without a fight. In August 2023, HHS announced the first ten drugs that will be available for Medicare price negotiation starting in 2026. The Department will undergo...

Read More


More Articles

AHIP Marketing Campaign Targets Pharma’s Prescription Drug Pricing

by Kelsey Waddill

AHIP has launched a marketing campaign targeting pharmaceutical companies and the role of prescription drug pricing in healthcare spending. “Let’s be clear, Big Pharma continues to...

Centene Announces Sale of Pharmacy Benefit Manager, Pharmacy

by Kelsey Waddill

Centene Corporation (Centene) has announced that the payer organization will sell both the pharmacy benefit manager Magellan Rx and pharmacy PANTHERx Rare.  Centene expects to make $2.8 billion...

Recent Articles